title: Protein kinase C mediates flow-induced prostaglandin E2 production in osteoblasts.
abstract: Interstitial fluid flow generated by skeletal loading may be responsible for load-induced bone remodeling. Production of prostaglandin E2 (PGE2), a potent mediator of bone remodeling, is augmented in osteoblasts exposed to fluid flow. Exposure to fluid flow resulted in a slight initial increase in PGE2 production (1-2 hour), followed by a dramatic increase (2-8 hours). The initial phase of only slightly increased PGE2 production was dependent on substrate availability. H7, a protein kinase C inhibitor, strongly inhibited flow-induced prostaglandin E2 production at all time points examined without effecting production in stationary cultures. Blocking protein synthesis with cycloheximide resulted in a 56% reduction in long-term flow-induced PGE2 production. Thus, the later phase appeared to be the result of an increased number of enzymes as well as increased activity of existing enzymes or increased substrate availability. In conclusion, fluid flow increases PGE2 production in osteoblasts via a protein kinase C-dependent pathway involving de novo protein synthesis.
authors.affiliation: Department of Chemical Engineering, Pennsylvania State University, University Park 16802.
authors.forename: K M
authors.initials: KM
authors.lastname: Reich
authors.forename: J A
authors.initials: JA
authors.lastname: Frangos
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000818:Animals; D016723:Bone Remodeling / Q000502:physiology*; D002478:Cells, Cultured; D015232:Dinoprostone / Q000096:biosynthesis*; D005110:Extracellular Space / Q000502:physiology; D007546:Isoquinolines / Q000494:pharmacology; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism*; D010879:Piperazines / Q000494:pharmacology; D014176:Protein Biosynthesis; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats; D012044:Regression Analysis; D013449:Sulfonamides
chemical_list: D007546:Isoquinolines; D010879:Piperazines; D013449:Sulfonamides; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; C043204:N-(2-guanidinoethyl)-5-isoquinolinesulfonamide; D011493:Protein Kinase C; D015232:Dinoprostone